MeSH tree: D08.811.682
A national team of cancer researchers led by Drs. Kenneth Shroyer and Natalia Marchenko at Stony Brook Medicine, and Dr. Luisa Escobar-Hoyos of Yale School of Medicine, investigated the role of Keratin 17 (K17) in the most ...
20 hours ago
0
3
For decades, physicians and scientists thought metformin, the leading type 2 diabetes medication taken by millions worldwide, mainly targets the liver to suppress glucose production. But a new Northwestern University study ...
May 8, 2026
0
172
A new set of drugs exploit a recently revealed weakness in "zombie-like"—or senescent—cells that could lead to new treatments for cancer and age-associated diseases. The study from the MRC Laboratory of Medical Sciences (LMS) ...
Apr 24, 2026
0
11
A new study from MIT suggests that a carcinogen that has been found in medications and in drinking water contaminated by chemical plants may have a much more severe impact on children than adults. In a study of mice, the ...
Apr 16, 2026
0
19
In a preclinical study published in Cancer Research, researchers from the University of Texas MD Anderson Cancer Center have identified one way that lung cancer becomes resistant to radiation therapy and then developed a ...
Apr 8, 2026
0
3
Alain Chariot's team has just published a study in EMBO Molecular Medicine shedding light on the unexpected role of the Stard7 protein in the development of intestinal cancers. Long regarded as a simple lipid transporter, ...
Apr 2, 2026
0
5
Researchers have created a detailed map of a deadly childhood cancer, showing it uses "shields" and "bodyguards" to protect itself, paving the way for new treatments. The team's paper, titled "Spatial multi-omics characterization ...
Mar 31, 2026
0
5
Treatment-resistant depression affects a large proportion of people with major depressive disorder, and while ketamine offers rapid relief, its antidepressant effects fade within a few weeks. Now, researchers from Japan have ...
Mar 30, 2026
0
3
UCLA researchers have uncovered a hidden weakness in some of the deadliest cancers, revealing a potential new strategy for targeting tumors that have long resisted treatment. Small cell neuroendocrine cancers, aggressive ...
Mar 23, 2026
0
47
A research team led by Associate Professor Shinpei Yamaguchi and the late Professor Masako Tada of the Faculty of Science, together with Professor Yojiro Anzai and Lecturer Yohei Iizaka of the Faculty of Pharmaceutical Sciences ...
Feb 28, 2026
0
8
